Did You Know: 97% of insured patients had coverage for PALYNZIQ*
You may pay as little as $0 with the PALYNZIQ Co-Pay Assistance Program† (For eligible, commercially insured patients).
Living with PKU can be challenging, but you’ve come to the right place to find support. BioMarin is committed to offering support and resources for those treating PKU with PALYNZIQ.
BioMarin RareConnections™ Case Managers provide one-on-one support from insurance coverage to ordering. They can also:
Work with your clinic on prior authorization and insurance coverage
Coordinate with specialty pharmacies to order and deliver your PALYNZIQ
Identify personalized financial support, including co-pay assistance
*Source: BioMarin RareConnections™ data. Jan–Dec 2022.
†Valid only for those with commercial insurance. Offer not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicare or any other federal or state program (including any state prescription drug assistance programs) (eg, VA, DoD, TriCare), for cash-paying patients, where product is not covered by patient’s commercial insurance, or where plan reimburses you for entire cost of your prescription drug. No claim for reimbursement of the out-of-pocket expense amount covered by the program shall be submitted to any third party payer, whether public or private. Offer is not valid where prohibited by law. Valid only in the United States and Puerto Rico. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. Co-payment assistance under the program is not transferable. BioMarin Pharmaceutical Inc. reserves the right to rescind, revoke or amend the program without notice. Patient certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. This program is subject to termination or modification at any time. The PALYNZIQ Co-Pay Assistance Program will cover up to $18,200 in assistance per calendar year for eligible patients. Some restrictions apply.
BioMarin Clinical Coordinators are available to provide ongoing product support and education, including:
I provide patients with education and support throughout every step of their medication journey. Before they even take their first dose, I’ll meet them at their home—or another place convenient for them—and give them all the background information on the medication they could ever want.”
—Leah, BioMarin Clinical Coordinator
Keep track of your PALYNZIQ treatment—and so much more with the myPAL app.
myPAL empowers you to track your treatment effortlessly and helps you focus on reaching your Phe level goals.
Available for Apple and Android
Stay connected with the PKU community.
Stay informed about managing PKU by attending an event or watching a live event on Facebook. If you attend an in-person event, you can meet other people living with PKU, learn about PKU management, and build your circle of support.
99% of participating patients paid $0 out-of-pocket for their prescription
The PALYNZIQ Co-Pay Assistance Program will cover all co-pay costs related to both your PALYNZIQ and auto-injectable epinephrine prescriptions, up to the annual maximum, for as long as you remain on therapy
Eligible patients will receive up to 3 fills of auto-injectable epinephrine per year at no additional cost
You can only get PALYNZIQ through the PALYNZIQ REMS program.
This ensures that you know about the risk of anaphylaxis when taking PALYNZIQ, and that you know about this risk before you start treatment.
Your clinic team can tell you more about the PALYNZIQ REMS and help you enroll.
Find a healthcare provider who will help you get enrolled in the PALYNZIQ REMS.
*Valid only for those with commercial insurance. Offer not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicare, Medicaid or any other federal or state program (including any state prescription drug assistance programs) (eg, VA, DoD, TriCare), for cash-paying patients, where product is not covered by patient’s commercial insurance, or where plan reimburses you for entire cost of your prescription drug. No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third-party payer, whether public or private. Offer is not valid where prohibited by law. Valid only in the United States and Puerto Rico. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. Co-payment assistance under the Program is not transferable. BioMarin Pharmaceutical Inc. reserves the right to rescind, revoke or amend the program without notice. Patient certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. This program is subject to termination or modification at any time.
Provide your contact information to receive important news and updates about PALYNZIQ.
BioMarin RareConnections™ can help with understanding insurance coverage and more.
What is the most important information I should know about PALYNZIQ?
PALYNZIQ can cause a severe allergic reaction (anaphylaxis) that may be life–threatening and may happen any time during treatment. Severe allergic reactions are a serious and common side effect of PALYNZIQ.
You will get your first injection under the supervision of a healthcare provider prepared to manage a severe allergic reaction. You will be watched for at least 1 hour after your injection for a severe allergic reaction.
Stop PALYNZIQ and get emergency medical care right away if you have any of the following signs or symptoms of a severe allergic reaction during treatment with PALYNZIQ: fainting (passing out); dizziness or lightheadedness; sudden confusion; trouble breathing or wheezing; chest discomfort or chest tightness; fast heart rate; swelling of your face, lips, eyes, or tongue; throat swelling or tightness; flushed or red skin; skin rash, itching, or raised bumps on skin; nausea, vomiting, or diarrhea; losing control of urine or stools.
PALYNZIQ REMS: PALYNZIQ is only available through a restricted program called the PALYNZIQ REMS (Risk Evaluation and Mitigation Strategy). Before you can receive PALYNZIQ, you must:
What should I tell my healthcare provider BEFORE starting PALYNZIQ?
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Tell your healthcare provider about all of your medical conditions, including if you:
What are the possible side effects of PALYNZIQ?
PALYNZIQ may cause serious side effects, including:
Injection site infections. Serious infections at the injection site have happened in people during treatment with PALYNZIQ. Some of these injection site infections required hospitalization, surgery, treatment with antibiotics given through the vein, or stopping treatment with PALYNZIQ. Change (rotate) your injection site and check your injection site for redness, swelling, or tenderness before each injection. Tell your healthcare provider right away if you develop signs or symptoms of an infection at your injection site that are new, do not go away, or get worse, including: pain, redness, swelling, or tenderness; the area feels hard; fluid or pus; blisters; a dark scab; an open wound.
Do not inject PALYNZIQ into the affected area until the infection has cleared.
The most common side effects of PALYNZIQ include: injection site reactions: redness, itching, pain, bruising, rash, swelling, tenderness; joint pain; allergic reactions; headache; skin reactions that spread and last at least 14 days, such as itching, rash, redness; nausea; stomach pain; vomiting; cough; mouth and throat pain; itching; diarrhea; stuffy nose; feeling very tired; dizziness; anxiety; low levels of Phe in your blood.
The most common side effects of PALYNZIQ in people 12 years to less than 18 years of age include: injection site reactions: redness, itching, pain, bruising, rash, swelling, tenderness; joint pain; headache; fever; allergic reactions; dizziness; nausea; vomiting; feeling very tired; pain in your arms or legs.
These are not all the possible side effects of PALYNZIQ. Call your healthcare provider for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Blood Phe testing and diet
Missed dose
Please see full Prescribing Information, including Important Warning, and the Medication Guide.
COM-ET-1199 02/26
What is the most important information I should know about PALYNZIQ?
PALYNZIQ can cause a severe allergic reaction (anaphylaxis) that may be life–threatening and may happen any time during treatment. Severe allergic reactions are a serious and common side effect of PALYNZIQ.
What is PALYNZIQ?
PALYNZIQ® (Pal-lin-zeek) (pegvaliase-pqpz) is a prescription medication used to lower blood levels of phenylalanine (Phe) in people 12 years and older with PKU (phenylketonuria) who have uncontrolled blood Phe levels above 600 micromol/L (10 mg/dL) on their current treatment. You should discuss the potential benefits and risks of PALYNZIQ with your healthcare provider.